The page lists 32 projects related to the topic "regimens".
| # | |||
|---|---|---|---|
| 1 | BIOCYCLE | BIOlogical therapy CYCLEs towards tailored, needs-driven, safer and cost-effective management of Crohn’s disease | 2015 |
| 2 | Subpopulations | Investigating Fibrotic and Regenerative Fibroblast Populations in Muscular Dystrophy | 2016 |
| 3 | BIMEDA | Big Medical Data Use in Primary Care: an ethnographic, socio-technical, investigation of challenges and opportunities | 2015 |
| 4 | VIRION | Viruses, Immune stimulation and RNA Interference in Oncology Network | 2015 |
| 5 | ChemoPredict | Predictive in vitro diagnostics test for individualized tailoring of chemotherapy in primary breast cancer | 2015 |
| 6 | ZAUBERKUGEL | Fulfilling Paul Ehrlich’s Dream: therapeutics with activity on demand | 2015 |
| 7 | HERCULES | Comprehensive characterization and effective combinatorial targeting of high-grade serous ovarian cancer via single-cell analysis | 2016 |
| 8 | REPROGRAM | Targeting epigenetic REPROGRamming of innate immune cells in Atherosclerosis Management and other chronic inflammatory diseases | 2016 |
| 9 | FutForm | Future Formulations: Developing Future Pharmaceuticals Through Advanced Analysis and Intersectoral Exchange | 2016 |
| 10 | OPTIM | Optimized drug combinations for effective cancer treatment: a personalised approach. | 2016 |
| 11 | HOW2WALKAGAIN | Mechanisms of recovery after severe spinal cord injury | 2016 |
| 12 | TREATMENT | Training European Network: Metabolic Dysfunctions associated with Pharmacological Treatment of Schizophrenia | 2017 |
| 13 | EPIPHARM | Development of a ncRNA DNA Methylation Kit for Treatment Guidance in Cancer of Unknown Primary | 2017 |
| 14 | CUPIDO | Cardio Ultraefficient nanoParticles for Inhalation of Drug prOducts | 2017 |
| 15 | EBODAC | Communication strategy and tools for optimizing the impact of Ebola vaccination deployment – Sofia ref.: 115847 | 2014 |
| 16 | HYBRID | Innovative Training Network towards raising and supporting the next generation of creative and entrepreneurial cross-speciality imaging experts | 2017 |
| 17 | iCHEMGENODRUGS_TB | Chemogenomics and in silico repurposing as an innovative approach for rapid drug discovery in tuberculosis | 2018 |
| 18 | EUSAT-RCS | European-Latin American TB Research Collaboration Network | 2019 |
| 19 | 20SInhibitor | Selective 20S proteasome inhibition for multiple myeloma therapy | 2019 |
| 20 | PDX-PC | Elucidation of tumour cell plasticity mechanisms associated to treatment in metastatic prostate cancer | 2019 |
| 21 | TT4CL | Clinical development of oral oleylphosphocholine as a new drug for the treatment of Old World Cutaneous Leishmaniasis | 2019 |
| 22 | MICROX | Microscopy of living cancer cells at physiological oxygen levels: the MICROX platform | 2019 |
| 23 | AB-DiRecT | Antibiotic Distribution and Recovery in Tissue | 2019 |
| 24 | GWAS2FUNC | From GWAS to functional studies: Tackling the complex nature of brain disorders | 2019 |
| 25 | IL7RsignaTHER | Antibody-based IL-7R targeted therapies | 2020 |
| 26 | CAPABLE | CAncer PAtients Better Life Experience | 2020 |
| 27 | mfloDx | Adaptable Multiflow Diagnostic Platform to Genetically Identify Drug Resistant Infection | 2019 |
| 28 | ImOPac | GemciTest: An innovative In Vitro Diagnostic for the decision-making process of pancreatic cancer treatment | 2019 |
| 29 | 4-IN THE LUNG RUN | 4-IN THE LUNG RUN: towards INdividually tailored INvitations, screening INtervals, and INtegrated co-morbidity reducing strategies in lung cancer screening | 2020 |
| 30 | ERA4TB | EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS | 2020 |
| 31 | DRTB-HDT | STRATIFIED HOST-DIRECTED THERAPY FOR DRUG-RESISTANT TUBERCULOSIS: A RANDOMIZED CONTROLLED MULTI-CENTRE TRIAL | 2020 |
| 32 | Trep-AB | Repurposing clinically approved antibacterial drugs for treponematoses therapy | 2020 |